Dispelling the Myths of Influenza Management
 
Release Date: December 19, 2019
Last Reviewed: December 17, 2019
Expiration Date: December 19, 2020
Time to Complete Activity: 1.0 hour
 
Faculty
Robert H. Hopkins, Jr, MD

Professor of Internal Medicine and Pediatrics
Chief, Division of General Internal Medicine
University of Arkansas for Medical Sciences (UAMS)
College of Medicine
Little Rock, AR
 
Steering Committee
Charles Vega, MD, FAAFP

Health Sciences Clinical Professor
University of California Irvine Department of Family Medicine
Assistant Dean for Culture and Community Education
University of California Irvine School of Medicine
Executive Director, University of California Irvine Program in Medical Education for the Latino Community
Santa Ana, CA

This activity is provided by Paradigm Medical Communications, LLC. 
 
Target Audience
This activity has been designed to address the educational needs of physicians, nurse practitioners, PAs, nurses, and pharmacists specializing in internal medicine, family medicine, infectious diseases, pediatrics, geriatrics, hospital medicine, critical care medicine, and obstetrics/gynecology. It may also benefit other clinicians who are interested or involved in the care of patients with influenza.
 
Statement of Need
Influenza is a serious disease associated with a host of negative consequences, including pneumonia, hospitalizations, and death. Patients who are at high risk for these influenza-related complications would benefit most from antiviral therapy, yet they are notoriously undertreated. Who are these vulnerable patients? And how is influenza best identified and managed, especially in high-risk patients? This activity will provide an update on influenza diagnosis and the role of antiviral therapies (including the first novel antiviral to be approved in more than 20 years), debunking common myths along the way. 
 
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
• Outline guideline-recommended testing for patients presenting with suspected influenza
• Select appropriate antiviral treatment for patients with influenza who are at risk for influenza-related complications
• Differentiate the mechanisms of action and clinical trial data of novel versus conventional antiviral therapies to determine how they may be used to reduce influenza-related complications
 
Table of Contents
• Introduction
• Myth #1: Most Patients With Influenza Are Not at Risk for Complications
• Myth #2: Laboratory Testing Is Needed to Confirm Influenza Before Antiviral Therapy Is Initiated
• Myth #3: Current Antiviral Agents Are Similar
• Q&A
 
Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Nursing Continuing Education
Educational Review Systems, Inc is an approved provider of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider # 5-115.  This program is approved for 1 hour of continuing nursing education.
 
Educational Review Systems, Inc is also approved for nursing continuing education by the state of California, the state of Florida, and the District of Columbia.
 
Pharmacist Accreditation and Designation Statement
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.0 hours (0.10 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
 
(Universal Activity Number: 0761-9999-19-213-H01-P; 0761-9999-19-213-H01-T)
 
This is a knowledge-based activity.
 
This activity is jointly provided by Educational Review Systems, Inc and Paradigm Medical Communications, LLC. 
                                                                                     

Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
 
PA Continuing Education
PAs may claim a maximum of 1.0 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
 
Disclosure of Commercial Support
This activity is supported by an educational grant from Genentech, Inc.
 
Instructions for Participation
To receive credit, you should:
• Follow instructions to register or log in with your professional information and complete the pre-activity assessment
• View the online activity in its entirety
• Complete and submit the online posttest and evaluation
A certificate of participation/statement of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
 
Please note: To claim CPE credit, please make sure you include your date of birth and NABP number. All credit information will be uploaded into CPE Monitor within 30 days.
 
For questions regarding CE credit, contact the Paradigm CME Department at (845) 398-5949.
 
There is no fee required for participation in this activity.
 
Hardware/Software Requirements
This certified CME/CPE activity is designed using HTML5 video. As you navigate the video using the supplied controls, the slides will sync to the speaker.
 
Supported Browsers:
For desktops (Windows/Mac)
Microsoft Edge 40 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
For tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher

Technical Support: If you have any technical problems or playback issues, email us at contactus@paradigmmc.com.

Disclosures
In accordance with ACCME, ACPE, and ANCC requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
 
Faculty and Steering Committee
Robert H. Hopkins, Jr, MD

No financial relationships to disclose.
 
Charles Vega, MD
Retained Consultant: Genentech, Inc
 
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
 
Educational Review Systems, Inc staff members have no financial relationships to disclose.
 
Independent peer reviewer has no financial relationships to disclose.
 
Independent fellow reviewer has no financial relationships to disclose.
 
Independent patient reviewer has no financial relationships to disclose.
 
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC and Educational Review Systems, Inc have implemented a system to resolve conflicts of interest for each CE activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CE content in this activity has been independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance, and the ANCC Guidelines, ACPE Guidelines, and ACCME’s Standards for Commercial Support of Continuing Medical Education.
 
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
 
Disclaimer
This CE activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC or Educational Review Systems, Inc. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
 
If included, signed statements of informed consent granting permission for use have been obtained for all photographs and videos in which an individual can be identified.
 
As accredited providers, Paradigm Medical Communications, LLC and Educational Review Systems, Inc must include a balanced view of therapeutic options in all activities. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC or Educational Review Systems, Inc.
 
Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CE activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC or Educational Review Systems, Inc. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC or Educational Review Systems, Inc. Paradigm Medical Communications, LLC and Educational Review Systems, Inc accept no liability for the content referenced in this activity.
 
Privacy policy
Paradigm Medical Communications, LLC and Educational Review Systems, Inc or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
 
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
 
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC and Educational Review Systems, Inc to continuously improve the learning experience.
 
Paradigm Medical Communications, LLC and Educational Review Systems, Inc do not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC and Educational Review Systems, Inc will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC and Educational Review Systems, Inc staff members review individual test results to the extent necessary to record and track participants’ credits.
 
Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
 
© 2019 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.